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Abstract
A healthy human body functions in sync with a wide array of gut microbes collectively 
known as human gut microbiome. They complement in a number of functions which are 
essential in our daily life such as in food metabolism. Various illnesses including colon cancer, 
autism, obesity, and autoimmune diseases have been linked to an imbalanced gut microbi-
ota. Antibiotics are indispensable drug; however, the administration of antibiotics in humans 
as well as in animal farms has shown to increase antimicrobial resistance genes (ARGs) in 
gut microbiome. This is of serious concern since the commensals in gut microbiome could 
capture ARGs through horizontal gene transfer which in turn could cause postsurgical infec-
tions. In addition, numerous studies have consistently shown that the gut microbiome is 
unique to each individual. Hence, in-depth knowledge on the gut microbiota community 
and the factor responsible for shaping and spreading of ARGs is essential. This would in 
turn enable the development of custom-tailored personalized food and drugs in the future.
Keywords: metagenomics, gut microbiome, antimicrobial resistance genes (ARGs) and 
gut resistome
1. Introduction
1.1. The gut microbiome and its significance
The human gut microbiome, also known as “second genome” [1], hosts over 100 trillion 
microorganisms [2] collectively covering over 150 folds more unique genes than the host [3, 
4]. Several projects such as the Human Microbiome Project, MyNewGut, and Meta-HIT have 
been initiated with the aim to understand the entirety and the functional potential of gut 
microbiome and to find possible strategies to benefit the host though the alteration of gut 
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microbiome [5]. The gut microbiome has been linked to various functions, some of which are 
discussed subsequently.
1.1.1. Gut microbiome is a necessary digestive “organ”
The gut microbiome is also considered as a “metabolically active organ” [6]. The distal human 
intestine is an anaerobic bioreactor consisting of numerous microbes having the ability to 
degrade and harvest nutrients which are otherwise inaccessible to the host [7]. In return, the 
host provides the raw materials and shelter to the microbiome. In this way, the host is relieved 
of various genotypic attributes which the microbiome complements. Studies have shown that 
the microbiome coevolved with us by having a mutualistic association [8]. It would seem that 
the microbiome might compete with the host for food and nutrients. However, conventional 
animals require 30% more calorie intake than the germfree counterparts in order to maintain 
the same body weight, implying that the microbiome actually aid in the host metabolism [9, 10].
1.1.2. Personalized gut microbiome
The gut microbiome, similar to fingerprint, has its own unique signature for every individual 
which is, however, very dynamic [11, 12]. The changes in the microbiota, also called dysbio-
sis, have also been associated to several health issues [13]. This has led to the possibility of 
personalized medicine and diet tailored uniquely for every individual depending on his/her 
unique microbiome [14].
1.1.3. The gut-microbiome-brain connection
Alterations in gut microbiota have also been linked to autism spectrum disorder (ASD) and 
gut-microbiome-brain connection. Maternal immune activation (MIA) mouse exhibits similar 
symptoms to ASD such as neurodevelopmental disorders, dysbiosis, alterations in gastroin-
testinal (GI), and serum metabolites [15–18]. Such MIA mouse when treated with Bacteroides 
fragilis improves intestinal permeability, tight junction proteins, and colon cytokines IL-6 
which is required by the MIA offspring for the development of behavioral deficits [9, 19]. 
Precursor 4-ethylphenol (4EP) found in MIA mice have also been shown to increase anxiety-
like behavior in naïve mice. 4EP is produced by several species of Clostridium which are also 
abundant in MIA mice. Treatment with B. fragilis resorts the 4EP level in MIA further support-
ing the role of microbiota in behavioral development [9].
1.2. Types of ARGs in gut microbiome resistome
The gut microbiome resistome can be broadly classified into intrinsic and mobile resis-
tance genes [20]. As the name suggests, intrinsic resistance genes are non-mobile resistance 
genes which are inherited and render tolerance to a particular drug without prior exposure. 
Although less mobile, there are possibilities of intrinsic resistance genes getting captured into 
mobile genetic elements (MGEs). Such events would turn it into mobile-resistant genes. Hence, 
studying such intrinsic resistance would provide knowledge on the mechanism and the pos-
sible treatment to tackle in case of outbreaks [20]. On the other hand, mobile resistomes are 
the resistance genes which are encoded in the highly mobile mobile genetic elements (MGE). 
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Mobile genetic elements include plasmids, transposons, integrons, integrative conjugative 
elements, genomic islands, and phages [20–25]. Resistance genes can get accumulated into a 
particular segment of DNA forming a special genomic island encoding multiple antimicrobial 
resistance genes (ARGs) called resistance islands (RIs). For instance, Acinetobacter baumannii 
Resistance Island of 86 kb is the largest known RI harboring 45 ARGs [26]. Resistance genes 
encode for proteins that render the microbe resistance to various antibiotics (Figure 1).
1.3. Factors that shape and spread gut microbiome ARGs
It is essential to understand the factors that shape and spread ARGs in the gut microbiome 
since gut microbiota regulates the human body in a diverse way, many of which are yet to 
Figure 1. Antibiotic resistance mechanisms: They are broadly classified into four types: (A) the influx of the antibiotics 
is disabled into the cell, (B) the antibiotics that manage to get into the cell is pumped out by active efflux pumps, (C) the 
target site for antibiotic in the cell is modified so that the antibiotic cannot bind, and (D) the antibiotics that enters the 
cells are degraded by the cell machinery.
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be known. It is indeed an important part of our body as discussed earlier which need special 
attention. However, the human gut microbiome is exposed to every food and drugs we con-
sume. The microbiota is, therefore, reflected by the dynamic nature it faces. Cataloging ARGs 
in gut microbiome is essential in order to study and determine the source and the possible 
measure to tackle the problem.
1.3.1. Horizontal gene transfer through mobile genetic elements
Mobile genetic elements (MGEs) are transferred between microbes through horizontal gene 
transfer (HGT) involving conjugation, transduction, and transformation. Transformation is 
the capturing of naked DNA from the environment into the microbe. If the naked DNA has 
ARG encoded in it, the microbe taking up the naked DNA would gain resistance owning to the 
resistant gene encoded in the naked DNA. However, such events are found to be considerably 
rare in the mammalian gut [27]. Hence, comparatively, conjugation and transduction seem to 
have a higher impact in ARG horizontal gene transfer [28]. Conjugation involves the formation 
of mating bridge though which the ARGs are transferred from the donor to the recipient cell. 
Bacterial HGTs are more common among the same phylogenetic taxa [29]. ARG transfer was 
boosted between the commensal Escherichia coli and other pathogens during gut inflammation 
[30]. However, ARG transfer through conjugation was significantly reduced between E. coli 
strains in the healthy human gut since the intestinal epithelial cells produce a proteinaceous 
compound [28, 31] which could interfere with the conjugative process. In transduction, the 
ARG is encoded in the bacteriophages which get incorporated into the host once the bacterio-
phages invade a bacterium. It is postulated that transduction could be a major player in gut 
resistome [32] since the amount of phages and bacteria is equivalent in the intestinal tract [33, 
34]. This is supported by the work of Goren et al. [35] showing that the phages isolated from 
antibiotic-treated mice when inoculated to aerobic microbiota culture showed higher ARG 
isolates when compared to culture which was treated with non-antibiotic-treated mice.
1.3.2. Gut resistome and antibiotic usage in farm animals
In the United States, nearly 80% of the antibiotics produced is used up in animal farm for 
treatment purposes [36]. As a result, the gut microbiome of farm animals is highly enriched 
in ARGs due to regular antibiotics treatment [37, 38]. ARGs enrichment up to 28,000 folds, 
including numerous unique ARGs, were detected in Chinese Swine farm [38] having efflux 
pumps, antibiotic deactivation, and cellular protection resistance mechanism. However, anti-
biotic-free organic pig guts were also found to harbor novel genes encoding resistance to the 
tetracyclines which were associated with putative mobile genetic elements [39]. Tetracycline 
resistance gene had the highest ratio of total ARGs according to a large-scale human gut 
microbiome analysis within the population from Denmark, Spain, and China. The study sug-
gests the possibility of tetracycline resistance gene being transferred from animals since tetra-
cyclines were highly used in animal farms [40, 41]. Subjects from country with comparatively 
tighter policies on antibiotic usages in humans and animals have considerably lesser ARG 
levels [42]. In addition, the antibiotic resistance genes revealed signature clustering of Chinese 
samples separate from other European countries thought single nucleotide polymorphisms 
(SNPs) analysis [41]. An independent study [43] on another population further supports this 
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idea of ARG signature. The country-wise signature patterns could be linked to different poli-
cies adapted in different countries [28].
1.3.3. Travelers and migratory birds spread ARGs
ARGs can also spread through traveling. In a study involving Swedish students exchange 
programs to India or Central Africa, the level of sulfonamide, trimethoprim, and beta-lactams 
were increased after the completion of the exchange programs [44]. The spread of ARGs can 
also be affected widely by migratory birds, which fly long distances [45].
1.3.4. Antibiotic therapy enriches ARGs
Gut microbiome is a reservoir of ARGs which can indirectly pass the ARGs into the environ-
ment. The application of antibiotics has been largely linked to increase in ARGs. Resistance to 
aminoglycosides was found to increase after admitting to intensive care unit (ICU) [46]. ARGs 
were also found to increase on patients after treatment with antibiotics [47]. Studies on large-
scale human gut samples from 10 different countries have shown that the ARGs in gut micro-
biome are highly influenced by the antibiotic usage and food products [48] while other factors 
such as age, sex, body mass index (BMI), and health status did not show significant contribu-
tion to ARGs level. The administration of cephalosporin, cefprozil, increased Lachnoclostridium 
bolteae in 16 out of 18 participants, as revealed from a study by Raymond et al. [49]. It also 
increased opportunistic pathogen Enterobacter cloacae in those participants whose initial micro-
biome diversity was comparatively lower. The treatment also enriched ARGs which were 
undetectable before the treatment. The alternation in the microbiome was specific to each 
subject, however, in a specific and reproducible manner. The authors, Raymond et al. [49], 
hypothesized that the initial analysis of microbiome before the treatment of antibiotics could 
bypass adverse effects during and after the antibiotic treatments. Nonetheless, the reduction 
of ARGs was seen in some studies when combinatorial antibiotic treatment was administrated 
[28, 46, 47]. This could happen when the resistant microbe is susceptible to another antibiotic 
when given in combination [28]. The application of antibiotic treatment, in addition to altera-
tion of gut microbiome, can also cause long-term persistence of the ARGs in the gut microbiota 
[50]. Hence, alternative approach to antibiotic therapy is of urgent need to avoid undesirable 
effects to the microbiota. Alternative therapies such as probiotic intervention, vaccination, and 
bacteriotherapy [51–54] have been developed. However, such alternative strategies are still at 
infancy stage; hence, focus on such strategies have to be encouraged.
1.4. Gut microbiome ARGs
Human gut microbiota is a home to numerous commensals, microbes that derive benefit from 
the host without causing harm. However, such commensals can acquire ARGs from microbes 
that are merely passing through the gut which can cause serious postsurgical infections [20]. 
In addition, disruption in the composition of gut microbiome in animal models has shown 
to cause non-communicable diseases (NCDs) such as colon cancer, autism, obesity, and auto-
immune diseases [55, 56]. Salyers et al. [57] proposed the concept of ARGs in human gut 
microbiome. Since then, the technological advancement in high-throughput robotic screening 
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and next-generation-sequencing (NGS) technologies in the last decade has pushed the gut 
microbiota research into full swing [20].
1.4.1. The infants’ gut resistome
The infant microbiota is highly dynamic and susceptible to antibiotics [58]. The disruption of 
microbiota at such stage could have significant ill effects throughout life by interfering with 
the metabolic and immune system [59]. The infant microbiota development is linked to vari-
ous factors such as the host genetic makeup, nutrition, and environment [60–62]. The micro-
biota of a new born baby, even without antibiotic treatment, harbors a diverse resistance gene 
in their resistome [63, 64]. However, antibiotic treatments increase the abundance of patho-
genic Enterobacteriaceae and lower healthy microbiota such as Bifidobacteriaceae, Bacilli, and 
Lactobacillales spp. [59, 65–67]. It is believed that the Lactobacillus and Bifidobacterium spp. are 
originated from maternal microbiome which is an essential component for the development of 
infant gut microbiome [62, 68]. The treatment of L. acidophilus and Bifidobacterium as probiotics 
in low birthweight infants increases the daily weight gain and recedes morbidity [69, 70], pos-
sibly by promoting the healthy gut microbiome and intestinal epithelial layer [58, 71]. The two 
modes of delivery, vaginally and C-section, can also distinctly affect an infant’s microbiota in 
the first year after delivery. Vaginally delivered infants harbor comparatively higher resem-
blance to mother’s microbiota [72]. Microbes such as Bacteroides and Bifidobacterium are less 
frequent in C-section-delivered infants; however, an increased frequency of bacteria is asso-
ciated to oral and skin [73]. Studies have also found that the microbiota of a 2-month infant 
and their mother shares distinction in resistome which includes broad-spectrum beta-lactam 
antibiotics to be found only in the infants [74]. In fact, comparison between infant and their 
mother to an unrelated infant showed no significant difference [74]. It is proposed that the host 
genetic makeup and the environmental factors could play a role in the shaping resistome [74]. 
Infant microbiota shapes into an adult-like by increasing the alpha diversity while reducing 
the beta diversity which continues until the age of 3 [60]. Maturation of the infant microbiota 
is also driven by the feeding habit. The addition of solid food does not induce the maturation 
of microbiota significantly. However, cessation of breastfeeding enriches the gut microbiota to 
adult-like [72]. Infants with breastfeeding are enriched by Bifidobacterium and Lactobacillus even 
at the age of 1 while infants who no longer breastfeed are enriched with Roseburia, Clostridium, 
and Anaerostipes, which are prevalent in adults. Functionally, polysaccharide-degrading genes 
are enriched only after the cessation of breastfeeding [72]. The microbiota also acquires sig-
nificant essential amino acids, irons, and vitamins genes after 4 months, which are essential 
for normal brain development [9, 75]. Functional metagenomics from healthy infants and 
children isolated three novel ARGs and also demonstrated that the ARG in gut resistome is 
significantly higher than previously estimated [64, 76].
1.4.2. The adult gut resistome
Large-scale metagenomic study of 252 fecal metagenomes samples identified 50 antibiotic 
classes [42]. Tetracycline resistance gene, tetQ, is the most abundant resistance gene in fecal 
samples of Chinese, Danish, and Spanish individuals. In fact, tetracycline resistance genes 
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were the most abundant genes in multiple studies [41, 42]. Although sufficient evidence for 
the diversity and abundance of ARGs have already been shown to light, the numbers could 
still be underestimated since during the annotation of metagenomic data, only those ARGs 
which have been identified and added into the database would yield a positive hit. This 
would exclude all the ARGs which have not yet been identified. For instance, 290 ARGs hav-
ing an average similarity of only 69.5% against the GenBank were isolated using functional 
metagenomics of fecal samples from two healthy individuals [77].
2. Conclusion
Gut microbiome is an essential “organ” without which the host would be deprived of various 
benefits derived from the numerous gut microbes. The benefits range from food metabolism 
to the mental health of the host. Hence, it requires attention as much as any other organ in 
our body. Various studies have, however, noticed the dynamic nature in the compositing and 
diversity of the gut microbiome making it one of the most dynamic “organs” in us. In addi-
tion, the wide application of antibiotic treatment for human as well as animals has enriched 
the gut ARGs. Hence, strict polices has to be implemented in order to maintain a moderate 
antibiotics usage. In addition, the surge in ARGs is a clear indication that the research on anti-
biotic alternative is a necessity for the coming future.
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